Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 25 November, 2008 and appeared in  Issue 444Type 2 DiabetesType 1 Diabetes

Researchers Discover Pure Insulin Cells That Treat Diabetes

A team of Singapore researchers has made a breakthrough in developing an unlimited number of pure insulin-producing cells from mouse embryonic stem cells that are highly effective in treating diabetes.

Advertisement

These pure insulin-producing cells have the same sub-cellular structures as the insulin-producing cells found in the pancreas, These pure insulin-producing cells have the same sub-cellular structures as the insulin-producing cells found in the pancreas, Singapore's Agency for Science, Technology and Research (A*STAR) announced Thursday.

The agency said the findings were made by researchers from the Institute of Medical Biology (IMB) under A*STAR and the Yong Loo Lin School of Medicine (YLLSoM ) at the National University of Singapore (NUS).

The researchers were co-led by Dr Lim Sai Kiang, a principal investigator with IMB and a research associate professor at the Department of Surgery, YLLSoM, and Dr Li Guodong, a research associate professor at National University Medical Institutes of NUS.

A*STAR said experiments by Dr Lim and Dr Li's group showed that when transplanted into diabetic mice with high blood glucose levels, the pure insulin-producing cells would cause the blood glucose levels of the animals to decrease.

The experiments also showed that the subsequent removal of the transplanted cells from the diabetic mice would restore the blood glucose to its original level.

It was also discovered that none of the diabetic mice involved in the transplants developed 'teratoma', a type of tumor often associated with embryonic stem cells which could complicate their use in therapeutic treatment.

The pure insulin-producing cells also managed to retain their insulin-production and glucose-sensing capacity over time.

A*STAR said the researchers' achievement provided proof of the principle that this strategy could be applied to human embryonic stem cells to obtain similar pure insulin-producing cells.

The research findings have been published in two papers in this year's online version of the journal, 'Stem Cell Research'.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 25 November, 2008 and appeared in  Issue 444Type 2 DiabetesType 1 Diabetes

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control